GB1391843A - X-ray contrast agents - Google Patents

X-ray contrast agents

Info

Publication number
GB1391843A
GB1391843A GB1634672A GB1634672A GB1391843A GB 1391843 A GB1391843 A GB 1391843A GB 1634672 A GB1634672 A GB 1634672A GB 1634672 A GB1634672 A GB 1634672A GB 1391843 A GB1391843 A GB 1391843A
Authority
GB
United Kingdom
Prior art keywords
salt
composition
ray contrast
april
contrast agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1634672A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of GB1391843A publication Critical patent/GB1391843A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent

Abstract

1391843 Radiopaque composition SCHERING AG 10 April 1972 [10 April 1971] 16346/72 Heading A5B An X-ray contrast composition comprises an aqueous solution of at least one watersoluble, physiologically-tolerable salt of 3-acetamido-5-hydroxyacetamido-2, 4, 6-triiodobenzoic acid, the salt(s) being present in an amount equivalent to 19.8-74.4g. of the acid per 100 ml of the composition. The salt may be a sodium, calcium, ethanolamine or N- methyl glucamine salt. The composition may also include disodium ethylene diamine tetraacetic acid salt. It may be enclosed in capsules.
GB1634672A 1971-04-10 1972-04-10 X-ray contrast agents Expired GB1391843A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2118219A DE2118219C3 (en) 1971-04-10 1971-04-10 New X-ray contrast medium

Publications (1)

Publication Number Publication Date
GB1391843A true GB1391843A (en) 1975-04-23

Family

ID=5804754

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1634672A Expired GB1391843A (en) 1971-04-10 1972-04-10 X-ray contrast agents

Country Status (15)

Country Link
AT (2) AT316523B (en)
AU (1) AU463194B2 (en)
BE (1) BE781889A (en)
CA (1) CA987339A (en)
CH (1) CH574740A5 (en)
DD (1) DD95265A5 (en)
DE (1) DE2118219C3 (en)
ES (1) ES401603A1 (en)
FR (1) FR2132810B1 (en)
GB (1) GB1391843A (en)
HU (1) HU163446B (en)
IL (1) IL39167A (en)
IT (1) IT1048929B (en)
NL (1) NL7204789A (en)
ZA (1) ZA722396B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641682A5 (en) * 1978-10-05 1984-03-15 Daeniker Felix X-ray contrast medium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076024A (en) * 1954-02-19 1963-01-29 Sterling Drug Inc Acylated 3, 5-diaminopolyhalobenzoic acids
DE1129260B (en) * 1961-05-12 1962-05-10 Schering Ag X-ray contrast media

Also Published As

Publication number Publication date
FR2132810A1 (en) 1972-11-24
IL39167A0 (en) 1972-06-28
DE2118219C3 (en) 1981-07-16
DE2118219B2 (en) 1980-07-03
AT318801B (en) 1974-11-25
DD95265A5 (en) 1973-01-20
AU4063372A (en) 1973-10-04
AT316523B (en) 1974-07-10
ES401603A1 (en) 1975-02-16
FR2132810B1 (en) 1975-03-14
ZA722396B (en) 1972-12-27
NL7204789A (en) 1972-10-12
DE2118219A1 (en) 1972-10-26
CA987339A (en) 1976-04-13
CH574740A5 (en) 1976-04-30
IL39167A (en) 1976-01-30
BE781889A (en) 1972-10-10
AU463194B2 (en) 1975-07-02
HU163446B (en) 1973-08-28
IT1048929B (en) 1980-12-20

Similar Documents

Publication Publication Date Title
DE3061347D1 (en) 2,4,6-triiodo-isophthalic acid derivatives, process for their preparation and x-ray contrast agents containing them
DE3479291D1 (en) Enteric contrast agent for nuclear spin tomography, and its preparation
DE3060592D1 (en) Derivatives of 2,4,6-triodo-isophthalic acid, process for their preparation and x-ray contrast agents containing them
MX9203271A (en) INJECTABLE OPASCIFYING COMPOSITION FOR X-RAY EXAMS.
IL48484A0 (en) 5-hydroxypropionylamino-2,4,6-triiodo-isophthalic acid bis-(dihydroxypropyl-amides),their preparation and use as x-ray contrast agents
EP0067130A3 (en) Capsules containing the active principle of an allergen, and process for their preparation
FR2285857B1 (en)
GEP19971155B (en) Contrast medium and method for its production
GB1417003A (en) Stabilisation of fibrinogen
PT76495B (en) Process for preparing new imidazolphenyl-tetrahydropyridazines
DE3061514D1 (en) Process for preparing pvp iodine
KR930700163A (en) Methods of treating and / or diagnosing soft tissue tumors
EP0153992A3 (en) Water soluble derivatives of 3,5-diaceto amido-2,4,6-triiodobenzoic acid and process for their preparation and use
CH557382A (en) PROCESS FOR THE PREPARATION OF ACID 7 - ((ALPHA) -HYDROXY- (ALPHA) -PHENYL) -ACETAMIDO-3- (1-METHYL-1H-TETRAZOL-5-YLTHIOMETHYL) -3-CEPHEM-4-CARBOXYL AND ITS DERIVATIVES.
GB1438919A (en) Compositions comprising chelated radioactive heave metals
GR60385B (en) New propargyl-2-phenylamino-imidazolines-(2),salts thereof by addition of their acids,pharmaceutical mediums containing the above and process for their preparation
ES411117A1 (en) Triiodoisophthalic acid monoamino acid amides
ES8306994A1 (en) Diamides of substituted hydroxymalonic acids, process for their preparation and their use as pesticides.
GB1391843A (en) X-ray contrast agents
BE786497A (en) SUPERIOR APPROVED FOR RETINOIC ACID, ITS SALTS AND THEIR PREPARATION
EG10508A (en) Method for preparation of 5-aryl 2,3-dihydro-2,2(or 3,3)dimethyl-5h-imidazo(2,1-a)isoindol-5-ols and 2(4,4(5,5)dimethyl-2-imidazolin-2-yl)bensophenone acid addition salts used as autidepressant drug
ES465180A1 (en) Immunoglobulin having a reduced complement fixation, a process for its preparation and agents containing this immunoglobulin
ES427653A1 (en) 3-Hydroxyacyl aminomethyl-5-acylamino-2,4,6-triiodobenzoic acid salts as x-ray contrast agents
JPS57146722A (en) Pharmaceutical preparation having improved absorption
GB1450524A (en) 2,4,6-triiodo-5-methoxyacetamido-n-methylisophthalamic acid and salts acyl halides and esters thereof

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee